Menu
Live News EQUITY M impact

Novo Nordisk: GLP-1 Pill Preferred

Novo Nordisk's US Chief reports twice as many Medicare patients prefer GLP-1 pill to shot

NVO

- It Is Uncertain Whether Medicare Will Offer Immediate RX Boost